NCT07173244View on ClinicalTrials.gov

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2029

Conditions
Non-Small Cell Lung CancerSmall Cell Lung CancerGastrointestinal Cancers
Interventions
DRUG

Adebrelimab

adebrelimab-based regimen

All Listed Sponsors
lead

Tianjin First Central Hospital

OTHER